Head and neck squamous cell carcinoma Trials in Pittsburgh, United States
Conditions / Head and neck squamous cell carcinoma / Pittsburgh, United States
Head and neck squamous cell carcinoma has been the subject of sustained clinical investigation across multiple research sites.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05877599 | A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation | RECRUITING | — |
| NCT04254107 | A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer | TERMINATED | PHASE1 |
| NCT04442126 | A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors | TERMINATED | PHASE1/PHASE2 |
| NCT04429542 | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT03258554 | Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin | COMPLETED | PHASE2/PHASE3 |
| NCT06147037 | A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours | RECRUITING | — |
| NCT04234113 | Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors | TERMINATED | PHASE1 |
| NCT05563272 | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors | TERMINATED | PHASE2 |
| NCT05576077 | A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors | TERMINATED | PHASE1 |
| NCT02734537 | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery | RECRUITING | PHASE2 |